Name	*NC/NA	1	2	3	4	5	All grades
Thyroid dysfunction	59%	41%	0%	0%	0%	0%	41%
Hypoalbuminemia	76%	24%	0%	0%	0%	0%	24%
Aspartate aminotransferase increased	76%	24%	0%	0%	0%	0%	24%
Alanine aminotransferase increased	82%	18%	0%	0%	0%	0%	18%
Lipase increased	88%	6%	0%	6%	0%	0%	12%
Fatigue	88%	12%	0%	0%	0%	0%	12%
Hyperuricemia	88%	12%	0%	0%	0%	0%	12%
Hypothyroidism	88%	0%	12%	0%	0%	0%	12%
Cardiac disorders—other, T-wave abnormality	88%	12%	0%	0%	0%	0%	12%
Leukopenia	88%	0%	12%	0%	0%	0%	12%
Blood bilirubin increased	88%	12%	0%	0%	0%	0%	12%
Neutrophil count decreased	88%	12%	0%	0%	0%	0%	12%
Pulmonary infection	94%	0%	0%	6%	0%	0%	6%
Respiratory failure	94%	0%	0%	0%	6%	0%	6%
Pneumonitis	94%	0%	6%	0%	0%	0%	6%
Platelet count decreased	94%	6%	0%	0%	0%	0%	6%

The table lists all the treatment-related AEs that occurred in 17(70.8%) patients.

*NC/NA indicates no change or no adverse event. Percentage NC/NA plus percentage all grades total to 100%.